Chief Executive Officer
Sophie has a distinguished career in healthcare having held senior positions at Johnson & Johnson, Sorin, CIT and Lifecell. She has extensive experience in sales and marketing, and particularly in bringing innovative technologies to market.
Chief Financial Officer
Erwan brings over 20 years of experience in finance, biotechnology and corporate development. Before joining Cellnovo, Erwan was Chief Financial Officer of Genomic Vision (Euronext: GV), a position he had held since 2009. He was also VP of Corporate Development until 2015, undertaking financing operations such as the Company's initial public offering. He has also worked at Syndex, and co-founded Cytomics Pharmaceuticals, a biotechnology company specialising in the discovery of new medicines.
Chief Operating Officer
Chris has over 25 years of experience in medtech, in particular the transfer of devices from R&D in production and their subsequent scale to large volume manufacture. He has worked at Owen Mumford (Auto injectors), Microvisk (Sensors), Sphere Medical (Biosensors) and Innovata (Inhalers) where he held senior management team roles.
VP Sales & Marketing
Didier is an entrepreneurial leader with extensive knowledge of the healthcare sector with over 30 years of experience in senior management positions. He has established European subsidiaries for multiple Biotech companies and specialises in building new businesses from the ground up, and accelerating their development internationally and locally. Didier holds a master in Biomedical engineering at the University Claude Bernard in Lyon, France.
Chief Scientific Officer and Founder
Julian has a cross-functional engineering and scientific background, specialising in Microsystems for drug discovery. Julian worked with the International Space School at NASA in Houston, Texas. He is also the inventor of Cellnovo's unique pump technology which serves as the cornerstone of the Cellnovo Mobile Diabetes Management System.